YS

Yedakathody Siddarth Hegde

Active Director Director DIN 11293940
DIN 11293940 First appointment Sep 2025 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Yedakathody Siddarth Hegde

Data last updated:

Yedakathody Siddarth Hegde is a Director at Suraj Biopharma Private Limited (since 2025). The company operates in Biotechnology.

DIN 11293940
Primary Designation Director
Industry Biotechnology
First Appointment 11 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Suraj Biopharma Private Limited U21001KA2025PTC208320
Director11 Sep 20252025Active

Board colleagues of Yedakathody Siddarth Hegde

NameDINCompanyDesignation
Sowkoor Sudhir Hegde11293941Suraj Biopharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Suraj Biopharma Private Limited
Premium access

Shareholding and investment profile for Yedakathody Siddarth Hegde

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yedakathody Siddarth Hegde

Yedakathody Siddarth Hegde currently holds 1 directorship: Suraj Biopharma Private Limited (Director, since 11 Sep 2025).

Yedakathody Siddarth Hegde was first appointed on 11 Sep 2025 as Director at Suraj Biopharma Private Limited.

The current boards of Yedakathody Siddarth Hegde's companies include Sowkoor Sudhir Hegde (Suraj Biopharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available